[S(R)]-N-[(1R)-1-[2-(二苯基膦)苯基]乙基]-2-叔丁基亚磺酰胺
[S(R)]-N-[(S)-[2-(二环己基膦)苯基](5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)甲基]-2-叔丁基亚磺酰胺
[S(R)]-N-[(S)-[3,5-二叔丁基-4-甲氧基苯基][2-(二环己基膦)苯基]甲基]-2-叔丁基亚磺酰胺
[S(R)]-N-[(1S)-1-[2-(二环己基膦)苯基]乙基]-N-甲基-2-叔丁基亚磺酰胺
[S(R)]-N-[(1S)-1-[2-(9-蒽基)苯基]-2-(二苯基膦)乙基]-N-甲基-2-叔丁基亚磺酰胺
[S(R)]-N-[(S)-[2-(二苯基膦)苯基]苯基甲基]-N-甲基-2-叔丁基亚磺酰胺
熔点 | 171-173 °C |
溶解性 | Soluble in DMSO (>50 mg/ml at 25 °C), water (8 mg/ml at 25 °C), and ethanol (7 mg/ml at 25 °C). |
应用 | A congener of fluorouracil. |
产品介绍 | Tegafur (FT-207, NSC 148958)用于治疗某些类型的癌症。 |
备注 | Ftorafur is a substance being used in the treatment of some types of cancer. |
生化机理 | Tegafur is a pro-drug of 5-fluorouracil, an antimetabolite used as an antineoplastic agent. It has been used as adjuvant chemotherapy for curatively resected colorectal cancer therapy. |
别名 | 5-氟-1-(四氢-2-糠基)尿嘧啶; 呋氟脲嘧啶;1-(四氢-2-呋喃基)-5-氟-2,4(1H,3H)-嘧啶二酮;四氢呋喃氟脲嘧啶;替加氟 ;5-Fluoro-1-(tetrahydro-2-furfuryl)uracil;Ftorafur |